RiteMED Pregabalin Use In Pregnancy & Lactation

Pregnancy: Pregnancy Category C: There are no adequate and well-controlled studies in pregnant women. Pregabalin should be used during pregnancy only if the potential benefit justifies the potential risk to the fetus.
Women of childbearing potential: As the potential risk for humans is unknown, effective contraception must be used in women of child bearing potential.
Labor and Delivery: The effects of pregabalin on labor and delivery in pregnant women are unknown.
Lactation: Pregabalin is excreted in the milk of breastfeeding women. As the safety of pregabalin in infants is not known, breastfeeding is not recommended in women taking pregabalin. A decision should be made whether to discontinue breastfeeding or to discontinue pregabalin therapy, taking into consideration the benefit of breastfeeding for the child and the benefit of therapy for the mother. Patients should be advised to notify their physician if they are breastfeeding.
Fertility: There are no clinical data on the effects of pregabalin on female fertility.
Pregabalin did not exhibit detrimental effects on the reproductive function of healthy male subjects, as measured by semen analysis, in a double-blind, placebo-controlled study to assess the effect of pregabalin on sperm motility.